BioCentury
ARTICLE | Company News

Cengent, Dynamis deal

November 22, 2004 8:00 AM UTC

Cengent will use its Genes to Leads lead identification technology to screen candidates against a target from Dynamis. The target is an enzyme that causes the formation of 3-deoxyglucosone, which is a...